AbbVie
ABBV
#27
Rank
โ‚ฌ328.63 B
Marketcap
185,80ย โ‚ฌ
Share price
1.78%
Change (1 day)
-2.34%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total assets

Total assets on the balance sheet as of December 2025 : โ‚ฌ116.78 Billion

According to AbbVie's latest financial reports the company's total assets are โ‚ฌ116.78 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

AbbVie - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2025-12-31โ‚ฌ114.03 B-12.2%
2024-12-31โ‚ฌ129.88 B6.59%
2023-12-31โ‚ฌ121.85 B-5.83%
2022-12-31โ‚ฌ129.40 B0.01%
2021-12-31โ‚ฌ129.38 B5.7%
2020-12-31โ‚ฌ122.41 B53.88%
2019-12-31โ‚ฌ79.55 B53.33%
2018-12-31โ‚ฌ51.88 B-12.06%
2017-12-31โ‚ฌ58.99 B-6.12%
2016-12-31โ‚ฌ62.84 B29.52%
2015-12-31โ‚ฌ48.51 B114.47%
2014-12-31โ‚ฌ22.62 B7%
2013-12-31โ‚ฌ21.14 B3.55%
2012-12-31โ‚ฌ20.41 B35.83%
2011-12-31โ‚ฌ15.03 B-5.4%
2010-12-31โ‚ฌ15.88 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
โ‚ฌ181.47 B 55.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ98.05 B-16.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ78.97 B-32.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ25.66 B-78.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ51.45 B-55.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ78.49 B-32.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ99.44 B-14.84%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚ฌ71.75 B-38.56%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
โ‚ฌ4.03 B-96.54%๐Ÿ‡บ๐Ÿ‡ธ USA